Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

FDG, MET or CHO? The quest for the optimal PET tracer for glioma imaging continues

Abstract

This Practice Point commentary discusses a study by Kato et al. that assessed the usefulness of three PET tracers— 11C-methionine (MET), 18F-fluorodeoxyglucose, and 11C-choline—for the metabolic evaluation of gliomas. The authors measured the ratio of tumor uptake to normal brain uptake (T/N ratio), with the frontal cortex as reference region, and analyzed the correlations between tracer uptake and tumor grade, type, and proliferation activity. Whereas all three tracers showed a similar correlation between the T/N ratio and tumor grade in astrocytic and oligodendroglial tumors, MET proved to be the most user-friendly marker in all gliomas as it enables the straightforward localization of 'hot lesions' and provides outstanding quantitative metabolic parameters. Here we highlight a few methodological issues arising from Kato et al.'s study and, consequently, we urge the PET community to reach a consensus on an objective approach towards the evaluation of PET tracers in the field of neuro-oncology.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Warburg O et al. (1924) Über den Stoffwechsel der Tumoren [German]. Biochemische Zeitschrift 152: 319–344. Reprinted in English in The Metabolism of Tumours by O Warburg (1930) London: Constable

    Google Scholar 

  2. Herholz K et al. (2007) Metabolic and molecular imaging in neuro-oncology. Lancet Neurol 6: 711–724

    Article  CAS  Google Scholar 

  3. Pirotte B et al. (2004) Combined use of 18F-fluorodeoxyglucose and 11C-methionine in 45 positron emission tomography-guided stereotactic brain biopsies. J Neurosurg 101: 476–483

    Article  CAS  Google Scholar 

  4. Borbély K et al. (2006) Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas. J Neurol Sci 246: 85–94

    Article  Google Scholar 

  5. Kato T et al. (2008) Metabolic assessment of gliomas using 11C-methionine, [18F] fluorodeoxyglucose, and 11C-choline positron-emission tomography. AJNR Am J Neuroradiol 29: 1176–1182

    Article  CAS  Google Scholar 

  6. Tian M et al. (2004) Comparison of 11C-choline PET and FDG PET for the differential diagnosis of malignant tumors. Eur J Nucl Med Mol Imaging 31: 1064–1072

    CAS  PubMed  Google Scholar 

  7. Narayanan TK et al. (2002) A comparative study on the uptake and incorporation of radiolabeled methionine, choline and fluorodeoxyglucose in human astrocytoma. Mol Imaging Biol 4: 147–156

    Article  CAS  Google Scholar 

  8. Di Chiro G et al. (1982) Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography. Neurology 32: 1323–1329

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Balázs Gulyás.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gulyás, B., Nyáry, I. & Borbély, K. FDG, MET or CHO? The quest for the optimal PET tracer for glioma imaging continues. Nat Rev Neurol 4, 470–471 (2008). https://doi.org/10.1038/ncpneuro0863

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneuro0863

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing